Pharmacolog i Uppsala AB (publ) / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €908.68K -1.8% -€1.67M -4.6% -183.9% +0.055 pp -€1.44M -12.9% -158.9% +0.20 pp
    €924.96K +14.7% -€1.75M +39.8% -189.5% -0.34 pp -€1.66M +24.7% -179.3% -0.14 pp
    €806.26K +363.8% -€1.25M -6.0% -155.5% +6.1 pp -€1.33M +45.3% -164.9% +3.6 pp
    €173.85K -12.9% -€1.33M -12.8% -767.4% -0.0070 pp -€915.05K -26.6% -526.3% +0.98 pp
    €199.55K +110.8% -€1.53M +35.1% -766.7% +4.3 pp -€1.25M +28.2% -624.6% +4.0 pp
    €94.65K +29.6% -€1.13M +24.5% -1,196.6% +0.49 pp -€971.89K +22.4% -1,026.8% +0.61 pp
    €73.01K +5,616.2% -€909.42K -11.5% -1,245.6% +790 pp -€793.82K +2.7% -1,087.3% +590 pp
    €1.28K +∞% -€1.03M +50.4% -80,459.7% -800 pp -€773.32K +53.6% -60,546.2% -610 pp
    €0.00 +NaN% -€683.07K +606.6% N/A -€503.37K -3,264.1% N/A
    €0.00 -€96.67K N/A €15.91K N/A

    Notifications